Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Teva
Citi
Dow
Fuji
Cerilliant
Baxter
UBS
McKinsey
Chinese Patent Office

Generated: February 20, 2018

DrugPatentWatch Database Preview

KEFLEX Drug Profile

« Back to Dashboard

When do Keflex patents expire, and when can generic versions of Keflex launch?

Keflex is a drug marketed by Pragma Pharms Llc and is included in two NDAs.

The generic ingredient in KEFLEX is cephalexin. There are twenty-nine drug master file entries for this compound. Sixty-three suppliers are listed for this compound. Additional details are available on the cephalexin profile page.
Drug patent expirations by year for KEFLEX
Pharmacology for KEFLEX
Medical Subject Heading (MeSH) Categories for KEFLEX

US Patents and Regulatory Information for KEFLEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pragma Pharms Llc KEFLEX cephalexin CAPSULE;ORAL 050405-002 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pragma Pharms Llc KEFLEX cephalexin FOR SUSPENSION;ORAL 050406-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pragma Pharms Llc KEFLEX cephalexin CAPSULE;ORAL 050405-005 May 12, 2006 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pragma Pharms Llc KEFLEX cephalexin CAPSULE;ORAL 050405-004 May 12, 2006 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pragma Pharms Llc KEFLEX cephalexin CAPSULE;ORAL 050405-003 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pragma Pharms Llc KEFLEX cephalexin FOR SUSPENSION;ORAL 050406-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pragma Pharms Llc KEFLEX cephalexin FOR SUSPENSION;ORAL 050406-003 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Daiichi Sankyo
Deloitte
Boehringer Ingelheim
Cipla
Dow
QuintilesIMS
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot